Application Nr Approved Date Route Status External Links
NDA020191 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage: AlomideĀ® (Lodoxamide Tromethamine Ophthalmic Solution) 0.1% Is Indicated In The Treatment Of The Ocular Disorders Referred To By The Terms Vernal Keratoconjunctivitis, Vernal Conjunctivitis, And Vernal Keratitis.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Lodoxamide Tromethamine LODOXAMIDE TROMETHAMINE ZINC896695

Comments